Jeffrey Roppe

1.4k total citations
19 papers, 1.1k citations indexed

About

Jeffrey Roppe is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Jeffrey Roppe has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Jeffrey Roppe's work include Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Jeffrey Roppe is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Jeffrey Roppe collaborates with scholars based in United States. Jeffrey Roppe's co-authors include Nicholas D. P. Cosford, Mark A. Varney, Lida Tehrani, Edwin J. Schweiger, Sara Rao, Nicholas D. Smith, Jesse Brodkin, Xiaohui Jiang, Mark Washburn and Linda J. Bristow and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Communications and Scientific Reports.

In The Last Decade

Jeffrey Roppe

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey Roppe United States	13	607	569	216	104	81	19	1.1k
J. Phillip Kennedy United States	21	683 1.1×	1.4k 2.5×	218 1.0×	98 0.9×	52 0.6×	32	1.8k
Samuel Hintermann Switzerland	19	384 0.6×	444 0.8×	248 1.1×	63 0.6×	168 2.1×	28	1.1k
Satyawan Jadhav United States	20	876 1.4×	1.1k 1.9×	120 0.6×	70 0.7×	84 1.0×	41	1.6k
Charles Gluchowski United States	21	600 1.0×	598 1.1×	351 1.6×	92 0.9×	50 0.6×	47	1.4k
Ryoko Yoshikawa Japan	15	481 0.8×	435 0.8×	258 1.2×	47 0.5×	54 0.7×	19	972
Hyekyung P. Cho United States	23	1.1k 1.7×	1.6k 2.8×	179 0.8×	84 0.8×	84 1.0×	58	1.9k
Alessandro Bonifazi United States	23	797 1.3×	979 1.7×	193 0.9×	68 0.7×	74 0.9×	68	1.4k
Lida Tehrani United States	13	683 1.1×	551 1.0×	192 0.9×	60 0.6×	124 1.5×	19	1.0k
Vanessa Barth United States	21	578 1.0×	623 1.1×	79 0.4×	145 1.4×	42 0.5×	36	1.0k
Tsing‐Bau Chen United States	17	708 1.2×	718 1.3×	127 0.6×	126 1.2×	67 0.8×	38	1.2k

Countries citing papers authored by Jeffrey Roppe

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Roppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Roppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Roppe more than expected).

Fields of papers citing papers by Jeffrey Roppe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Roppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Roppe. The network helps show where Jeffrey Roppe may publish in the future.

Co-authorship network of co-authors of Jeffrey Roppe

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Roppe. A scholar is included among the top collaborators of Jeffrey Roppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Roppe. Jeffrey Roppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Poon, Michael M., Karin J. Stebbins, Christopher Baccei, et al.. (2024). Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis. Scientific Reports. 14(1). 10573–10573. 3 indexed citations

Stebbins, Karin J., Jeffrey Roppe, Christopher Baccei, et al.. (2024). Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proceedings of the National Academy of Sciences. 121(32). e2407974121–e2407974121. 14 indexed citations

Gallezot, Jean‐Dominique, Nabeel Nabulsi, Daniel Holden, et al.. (2017). Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand ¹¹C-BMT-136088 for Lung Imaging in Rhesus Monkeys. Journal of Nuclear Medicine. 59(2). 327–333. 13 indexed citations

Stock, Nicholas, Gretchen Bain, Yiwei Li, et al.. (2011). 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor. Journal of Medicinal Chemistry. 54(23). 8013–8029. 39 indexed citations

Stock, Nicholas, Deborah L. Volkots, Karin J. Stebbins, et al.. (2010). Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(3). 1036–1040. 9 indexed citations

Lorrain, Daniel S., Gretchen Bain, Lucia Correa, et al.. (2010). Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. European Journal of Pharmacology. 640(1-3). 211–218. 19 indexed citations

Chapman, Charles W., Lucia Correa, Gretchen Bain, et al.. (2010). Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist. Journal of Pharmacology and Experimental Therapeutics. 336(3). 693–700. 101 indexed citations

Symons, Kent T., Mark E. Massari, Jeffrey Roppe, et al.. (2009). KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization. Molecular Pharmacology. 76(1). 153–162. 11 indexed citations

Bonnefous, Céline, Joseph E. Payne, Jeffrey Roppe, et al.. (2009). Discovery of Inducible Nitric Oxide Synthase (iNOS) Inhibitor Development Candidate KD7332, Part 1: Identification of a Novel, Potent, and Selective Series of Quinolinone iNOS Dimerization Inhibitors that are Orally Active in Rodent Pain Models. Journal of Medicinal Chemistry. 52(9). 3047–3062. 57 indexed citations

10.

Tehrani, Lida, Nicholas D. Smith, Dehua Huang, et al.. (2005). 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: Identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(22). 5061–5064. 10 indexed citations

11.

Hamill, Terence G., Stephen M. Krause, Christine Ryan, et al.. (2005). Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse. 56(4). 205–216. 124 indexed citations

12.

Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2005). 2‐{2‐[3‐(Pyridin‐3‐yloxy)phenyl]‐2H‐tetrazol‐5‐yl}pyridine: A Highly Potent, Orally Active, Metabotropic Glutamate Subtype 5 (mGlu5) Receptor Antagonist.. ChemInform. 36(14). 1 indexed citations

13.

Huang, Dehua, Steve F. Poon, Deborah F. Chapman, et al.. (2004). 2-{2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl}pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 14(22). 5473–5476. 25 indexed citations

14.

Roppe, Jeffrey, Bowei Wang, Dehua Huang, et al.. (2004). 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3′-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Bioorganic & Medicinal Chemistry Letters. 14(15). 3993–3996. 41 indexed citations

15.

Smith, Nicholas D., Steve F. Poon, Dehua Huang, et al.. (2004). Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 14(22). 5481–5484. 12 indexed citations

16.

Cosford, Nicholas D. P., Jeffrey Roppe, Lida Tehrani, et al.. (2003). [3H]-Methoxymethyl-MTEP and [3H]-Methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor. Bioorganic & Medicinal Chemistry Letters. 13(3). 351–354. 123 indexed citations

17.

Anderson, Jeffery J., Margaret Bradbury, Deborah F. Chapman, et al.. (2003). In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine). European Journal of Pharmacology. 473(1). 35–40. 124 indexed citations

18.

Cosford, Nicholas D. P., Lida Tehrani, Jeffrey Roppe, et al.. (2002). 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]- pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity. Journal of Medicinal Chemistry. 46(2). 204–206. 348 indexed citations

19.

Hurley, Dennis J., Jeffrey Roppe, & Yitzhak Tor. (1999). Coordination compounds as building blocks: simple synthesis of RuII-containing amino acids and peptides. Chemical Communications. 993–994. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact